BIOA
BioAge Labs (BIOA)
$46
About BioAge Labs (BIOA)
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.
Details
Daily high
$13.05
Daily low
$12.30
Price at open
$12.98
52 Week High
$13.10
52 Week Low
$2.88
Market cap
461.8M
Dividend yield
0.00%
Volume
560,051
Avg. volume
428,856
P/E ratio
-6.09
BioAge Labs News
Details
Daily high
$13.05
Daily low
$12.30
Price at open
$12.98
52 Week High
$13.10
52 Week Low
$2.88
Market cap
461.8M
Dividend yield
0.00%
Volume
560,051
Avg. volume
428,856
P/E ratio
-6.09